Cloning and purification of functionally active Fas ligand interfering protein (FIP) expressed in Escherichia coli

Acta Biochimica Polonica

Volumn 55, Issue 1, 2008, Pages 51-56

  Wisniewski, Pawel ^a   Master, Adam ^a   Kaminska, Bozena ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Apoptosis; Fas; Fas ligand; Interfering molecules; Recombinant protein purification

Indexed keywords

ESCHERICHIA COLI; RATTUS;

EID: 41549097673     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2008_3200     Document Type: Article

References (23)

1. Barnhart BC, Legembre P, Pietras E, Bubici E, Franzoso G, Peter ME (2004) CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 23: 3175-3185.
2. Blum H, Bayer H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
3. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz DJ (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762.
4. Choi C, Benveniste EN (2004) Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses. Brain Res Brain Res Rev 44: 65-81.
5. Ciesielski-Treska J, Ulrich G, Taupenot L, Chasserot-Golaz S, Zwiller J, Revel MO, Aunis D, Bader MF (2001) Mechanisms underlying neuronal death induced by chromogranin A-activated microglia. J Biol Chem 276: 13113-13120.
6. Curtin JF, Cotter TG (2003) Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal 15: 983-992.
7. Ethell DW, Buhler LA (2003) Fas ligand-mediated apoptosis in degenerative disorders of the brain. J Clin Immunol 23: 363-370.
8. Green DR (2003) Introduction: apoptosis in the development and function of the immune system. Semin Immunol 15: 121-123.
9. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 18: 2714-2723.
10. Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268: 10932-10937.
11. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407: 789-795.
12. Li Y, Yang X, Nguyen AH, Brockhausen I (2007) Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells. Int J Biochem Cell Biol 39: 1625-1636.
13. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365.
14. Peitsch MC (1995) Protein modeling by E-mail. Bio/Technology 13: 658-660.
15. Raoul C, Henderson CE, Pettmann B (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol 29: 1049-1061.
16. Ryan AE, Shanahan F, O'Connell J, Houston AM (2005) Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo. Cancer Res 65: 9817-9823.
17. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME (1998) Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687.
18. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385.
19. Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962.
20. Starling GC, Bajorath J, Emswiler J, Ledbetter JA, Aruffo A, Kiener PA (1997) Identification of amino acid residues important for ligand binding to Fas. J Exp Med 185: 1487-1492.
21. Starling GC, Kiener PA, Aruffo A, Bajorath J (1998) Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40. Biochemistry 37: 3723-3726.
22. Wajant H, Pfizenmaier K, Scheurich P (2003) Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 14: 53-66.
23. Zawadzka M, Kaminska B (2005) A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells. Glia 49: 36-51.